{
    "SPADE_UN_14289": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_14289",
            "Peptide Name": "MT-WQ-EKN",
            "Source": "Synthetic construct",
            "Family": "Retroviridae",
            "Gene": "Not found",
            "Sequence": "MTWEEWDKKIEEYTKKIEELIKKSQNQQEKN",
            "Sequence Length": 31,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Q5DP94"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.1±0.1 nM);HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.8±0.1 nM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry",
            "Binding Target": "membrane",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Acetylation",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C175H277N45O57S",
            "Mass": 3955.4,
            "PI": 5.26,
            "Net Charge": -1,
            "Hydrophobicity": -1.9,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Mechanism of action": "The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.",
            "Literature": [
                {
                    "Title": "Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.",
                    "Pubmed ID": "31277353",
                    "Reference": "Viruses. 2019 Jul 3;11(7)609.",
                    "Author": "Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31277353"
                }
            ],
            "Frequent Amino Acids": "EKI",
            "Absent Amino Acids": "ACFGHOPRUV",
            "Basic Residues": 7,
            "Acidic Residues": 8,
            "Hydrophobic Residues": 8,
            "Polar Residues": 16,
            "Positive Residues": 7,
            "Negative Residues": 8,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_14197",
                    "Similarity": 1.0,
                    "Sequence": "MTWEEWDKKIEEYTKKIEELIKKSQNQQ"
                },
                {
                    "SPADE_ID": "SPADE_UN_14284",
                    "Similarity": 1.0,
                    "Sequence": "MTWEEWDKKIEEYTKKIEELIKKS"
                },
                {
                    "SPADE_ID": "SPADE_UN_14285",
                    "Similarity": 1.0,
                    "Sequence": "MTWEEWDKKIEEYTKKIEELIKK"
                }
            ]
        }
    }
}